ii Human serum albumin (HSA) is a highly abundant protein in the human plasma, causing the discovery of new biomarkers challenging. Here we introduced a new method: aptamers as new affinity ligands for the depletion of HSA from serum. Aptamers are short RNA or DNA oligonucleotides (15-120 nucleotides) that bind to different targets, including proteins, peptides, and cells. Aptamers are like chemical antibodies, able to form 3-dimensional structures with targets and bind with high affinity and specificity. In this research, we selected aptamers against recombinant HSA (rHSA) using two different combinatorial DNA libraries: N40 and structured DNA. The method we used is called Nonequilibrium Capillary Electrophoresis of Equilibrium Mixture (NE...
The potential to emulate or enhance antibodies with nucleic acid aptamers while lowering costs has p...
An aptamer is a short sequence of synthetic oligonucleotides which bind to their cognate target, spe...
Nucleic acid ligands, aptamers, harbor the unique characteristics of small molecules and antibodies....
In DNA aptamer selection, existing methods do not discriminate aptamer sequences based on their bind...
Biological reagents that recognize target molecules with high affinity and specificity are widely us...
Molecular recognition of disease biomarkers is essential for the detection, monitoring, and treatmen...
Aptamers are an emerging class of molecules that are valued for their ability to bind with high affi...
Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein...
Background: Nucleic acids based therapeutic approaches have gained significant interest in recent ye...
This study reports a novel aptamer selection method based on microscale electrophoretic filtration. ...
Nucleic acids based therapeutic approaches have gained significant interest in recent years towards ...
Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein...
We describe an innovative selection approach to generate self-reporting aptamers (SRAs) capable of c...
BACKGROUND: Nucleic acids based therapeutic approaches have gained significant interest in recent ye...
BACKGROUND: Nucleic acids based therapeutic approaches have gained significant interest in recent ye...
The potential to emulate or enhance antibodies with nucleic acid aptamers while lowering costs has p...
An aptamer is a short sequence of synthetic oligonucleotides which bind to their cognate target, spe...
Nucleic acid ligands, aptamers, harbor the unique characteristics of small molecules and antibodies....
In DNA aptamer selection, existing methods do not discriminate aptamer sequences based on their bind...
Biological reagents that recognize target molecules with high affinity and specificity are widely us...
Molecular recognition of disease biomarkers is essential for the detection, monitoring, and treatmen...
Aptamers are an emerging class of molecules that are valued for their ability to bind with high affi...
Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein...
Background: Nucleic acids based therapeutic approaches have gained significant interest in recent ye...
This study reports a novel aptamer selection method based on microscale electrophoretic filtration. ...
Nucleic acids based therapeutic approaches have gained significant interest in recent years towards ...
Nucleic acid-based aptamers offer many potential advantages relative to antibodies and other protein...
We describe an innovative selection approach to generate self-reporting aptamers (SRAs) capable of c...
BACKGROUND: Nucleic acids based therapeutic approaches have gained significant interest in recent ye...
BACKGROUND: Nucleic acids based therapeutic approaches have gained significant interest in recent ye...
The potential to emulate or enhance antibodies with nucleic acid aptamers while lowering costs has p...
An aptamer is a short sequence of synthetic oligonucleotides which bind to their cognate target, spe...
Nucleic acid ligands, aptamers, harbor the unique characteristics of small molecules and antibodies....